Researchers at the University of Michigan Health Rogel Cancer Centre have discovered a mechanism that causes important gastrointestinal difficulties during immune-based cancer treatment.
A discovery that may result in novel medicines to halt or reverse the disease could be beneficial to patients with a rare genetic bone marrow problem who are at an elevated risk of blood malignancies.
Excessive activity of a limited number of brain cells causes several brain illnesses, including epilepsy. These diseases frequently do not react well to drug treatment, owing to the fact that drug influence the entire brain. A recent study revealed gene therapy to for neurological disorder.